Morgan Stanley upgrades Merck to Overweight, raises target to $179
Morgan Stanley upgrades Merck to Overweight from Equalweight and lifts its price target on Merck to $179 from $116.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.